Dopamine, reward, and frontostriatal circuitry in impulse control disorders in Parkinson's disease: Insights from functional imaging

Clinical EEG and Neuroscience

Volumn 41, Issue 2, 2010, Pages 87-93

  Ray, Nicola ^a   Strafella, Antonio P ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Dopamine; Dopamine receptor; Impulse control disorders; Parkinson's disease; Pathological gambling; Positron emission tomography

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE;

ADDICTION; COMPULSION; CORPUS STRIATUM; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; FRONTAL LOBE; HUMAN; IMPULSE CONTROL DISORDER; LEARNING; NEGATIVE FEEDBACK; NERVE CELL MEMBRANE POTENTIAL; NERVE CELL NETWORK; NEUROBIOLOGY; NEUROIMAGING; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; POSITIVE FEEDBACK; PRIORITY JOURNAL; REVIEW; REWARD;

EID: 77952989833     PISSN: 15500594     EISSN: None     Source Type: Journal    
DOI: 10.1177/155005941004100208     Document Type: Review

References (68)

1. Rowe JB, Hughes L, Ghosh BCP, Eckstein D, Williams-Gray CH, Fallon S, et al. PD and dopaminergic therapy - differential effects on movement, reward and cognition. Brain: A Journal of Neurology 2008; 131(Pt 8): 2094-2105. doi: 10.1093/brain/awn112.
2. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in PD. Neuroscience and Biobehavioral Reviews 2006; 30(1): 1-23. doi: 10.1016/j.neubiorev.2005.03.024.
3. Park A, Stacy M. (2009). Non-motor symptoms in PD. Journal of Neurology 2009; 256 (suppl 3): 293-298. doi: 10.1007/s00415-009-5240-1.
4. Evans AH, Strafella AP, Weintraub D, Stacy M. Impulsive and compulsive behaviors in PD. Movement Disorders: Official Journal of the Movement Disorder Society 2009; 24(11): 1561-1570. doi: 10.1002/mds.22505.
5. Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006; 67(7): 1254-1257. doi: 10.1212/01.wnl.0000238503.20816.13.
6. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Archives of Neurology 2007; 64(8): 1089-1096. doi: 10.1001/archneur.64.8.1089.
7. Voon V, Potenza MN, Thomsen T. Medication-related impulse control and repetitive behaviors in PD. Current Opinion in Neurology 2007; 20(4): 484-492. doi: 10.1097/WCO.0b013e32826fbc8f.
8. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Archives of Neurology 2006; 63(7): 969-973. doi: 10.1001/archneur.63.7.969. (Pubitemid 44036299)
9. Weintraub D. Dopamine and impulse control disorders in Parkinson's disease. Annals of Neurology 2008; 64 (suppl 2): S93-100. doi: 10.1002/ana.21454.
10. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy MA, Whetteckey J, et al. Dopaminergic Therapy and Impulse Control Disorders in PD: Top Line Results of a Cross-Sectional Study of Over 3,000 Patients 12th International Congress of Parkinson's Disease and Movement Disorders 2008; Chicago: June 22-26.
11. Nirenberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Movement Disorders: Official Journal of the Movement Disorder Society 2006; 21(4): 524-529. doi: 10.1002/mds.20757.
12. Grasset KA, Macphee G, Pal G, Stewart D, Watt A, Davie J, et al. Problematic gambling on dopamine agonists: not such a rarity. Movement Disorders: Official Journal of the Movement Disorder Society 2006; 21(12): 2206-2208. doi: 10.1002/mds.21110.
13. Grosset KA, Grosset DG, Macphee G, Pal G, Stewart D, Watt A, et al. Dopamine agonists and pathological gambling. Parkinsonism & Related Disorders 2007; 13(4): 259; auth. rep. 260. doi: 10.1016/j.parkreldis.2006.08. 003.
14. Lu C, Bharmal A, Suchowersky O. Gambling and Parkinson disease. Archives of Neurology 2006; 63(2): 298. doi: 10.1001/archneur.63.2.298-a.
15. Weintraub D, Potenza MN. Impulse control disorders in PD. Current Neurology and Neuroscience Reports 2006; 6(4): 302-306.
16. van Eimeren T, Ballanger B, Pellecchia G, Miyasaki JM, Lang AE, Strafella AP. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in PD? Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2009; 34(13): 2758-2766. doi: 10.1038/sj.npp.npp2009124.
17. van Eimeren T, Pellecchia G, Miyasaki J, Ballanger B, Steeves T, Houle S,et al. Dopamine agonists reduce baseline activity, but boost gambling related activity in the orbitofrontal cortex. A PET activation study in PD patients. Mov Disord 2009; 24:Suppl 1.
18. 11C] raclopride PET study. Brain: A Journal of Neurology 2009; 132(Pt 5): 1376-1385. doi: 10.1093/brain/awp054.
19. Riba J, Krämer UM, Heldmann M, Richter S, Münte TF. Dopamine agonist increases risk taking but blunts reward-related brain activity. PloS One 2008; 3(6): e2479. doi: 10.1371/journal.pone.0002479.
20. Hollander E, Wong CM. Body dysmorphic disorder, pathological gambling, and sexual compulsions. The Journal of Clinical Psychiatry 1995; 56 (suppl 4): 7-12; discussion 13.iorillo.
21. Brewer JA, Potenza MN. The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochemical Pharmacology 2008; 75(1): 63-75. doi: 10.1016/j.bcp.2007.06.043.
22. Potenza MN. Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 2008; 363(1507): 3181-3189. doi: 10.1098/rstb.2008.0100.
23. Grant JE, Brewer JA, Potenza MN. The neurobiology of substance and behavioral addictions. CNS Spectrums 2006; 11(12): 924-930.
24. Blanco C, Moreyra P, Nunes EV, Sáiz-Ruiz J, Ibáñez A. Pathological gambling: addiction or compulsion? Seminars in Clinical Neuropsychiatry 2001; 6(3): 167-176.
25. Belin D, Jonkman S, Dickinson A, Robbins TW, Everitt BJ. Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction. Behavioural Brain Research 2009; 199(1): 89-102. doi: 10.1016/j.bbr.2008.09.027.
26. Grant JE, Kim SW. Clinical characteristics and associated psychopathology of 22 patients with kleptomania. Comprehensive Psychiatry 2002; 43(5): 378-384.
27. McElroy SL, Pope HG, Hudson JI, Keck PE, White KL. Kleptomania: a report of 20 cases. The American Journal of Psychiatry 1991; 148(5): 652-657.
28. McElroy SL, Keck PE, Pope HG, Smith JM, Strakowski SM. Compulsive buying: a report of 20 cases. The Journal of Clinical Psychiatry 1994; 55(6): 242-248.
29. Sellman JD, Adamson S, Robertson P, Sullivan S, Coverdale J. Gambling in mild-moderate alcohol-dependent outpatients. Substance Use & Misuse 2002; 37(2): 199-213.
30. Mirenowicz J, Schultz W. Importance of unpredictability for reward responses in primate dopamine neurons. Journal of Neurophysiology 1994; 72(2): 1024-1027.
31. Di Chiara G. Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behavioural Brain Research 2002; 137(1-2): 75-114.
32. Bassareo V, Di Chiara G. Differential influence of associative and nonassociative learning mechanisms on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 1997; 17(2) 851-861.
33. Lecca D, Cacciapaglia F, Valentini V, Gronli J, Spiga S, Di Chiara G. Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration. Psychopharmacology 2006; 184(34): 435-446. doi: 10.1007/s00213-005-02804. (Pubitemid 43255860)
34. Bassareo V, De Luca MA, Di Chiara G. (2007). Differential impact of pavlovian drug conditioned stimuli on in vivo dopamine transmission in the rat accumbens shell and core and in the prefrontal cortex. Psychopharmacology 2007; 191(3): 689-703. doi: 10.1007/s00213-006-0560-7.
35. Di Chiara G, Bassareo V. Reward system and addiction: what dopamine does and doesn't do. Current Opinion in Pharmacology 2007; 7(1): 69-76. doi: 10.1016/j.coph.2006.11.003.
36. Nauta WJ, Domesick VB. Afferent and efferent relationships of the basal ganglia. Ciba Foundation Symposium 1984; 107: 3-29.
37. Volkow ND, Wang G, Telang F, Fowler JS, Logan J, Childress A, et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2006; 26(24): 6583-6588. doi: 10.1523/J NEUROSCI.1544-06.2006.
38. Fiorillo CD, Tobler PN, Schultz W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science (New York, N.Y.) 2003; 299(5614): 1898-1902. doi: 10.1126/science.1077349. (Pubitemid 36356659)
39. Zack M, Poulos CX. Parallel roles for dopamine in pathological gambling and psychostimulant addiction. Current Drug Abuse Reviews 2009; 2(1): 11-25.
40. Clark L, Lawrence AJ, Astley-Jones F, Gray N. Gambling near-misses enhance motivation to gamble and recruit win-related brain circuitry. Neuron 2009; 61(3): 481-490. doi: 10.1016/j.neuron.2008.12.031.
41. Hurd YL, Ungerstedt U. Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse (New York, N.Y.) 1989; 3(1): 48-54. doi: 10.1002/syn.890030107.
42. Volkow ND, Fowler JS, Wang G. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology 2004; 47 Suppl 1: 3-13. doi: 10.1016/j.neuropharm.2004.07.019.
43. Reuter J, Raedler T, Rose M, Hand I, Glāscher J, Büchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nature Neuroscience 2005; 8(2): 147-148. doi: 10.1038/nn1378. (Pubitemid 40194043)
44. de Ruiter MB, Veltman DJ, Goudriaan AE, Oosteriaan J, Sjoerds Z, van den Brink W. Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2009; 34(4): 1027-1038. doi: 10.1038/npp.2008.175.
45. Nader MA, Morgan D, Gage HD, Nader SH, Calhoun TL, Buchheimer N, et al. PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nature Neuroscience 2006; 9(8): 1050-1056. doi: 10.1038/nn1737. (Pubitemid 44264918)
46. Wexler BE, Gottschalk CH, Fulbright RK, Prohovnik I, Lacadie CM, Rounsaville BJ, et al. Functional magnetic resonance imaging of cocaine craving. The American Journal of Psychiatry 2001; 158(1): 86-95. (Pubitemid 32047251)
47. Potenza MN, Steinberg MA, Skudlarski P, Fulbright RK, Lacadie CM, Wilber MK, et al. Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Archives of General Psychiatry 2003; 60(8): 828-836. doi: 10.1001/archpsyc.60.8.828. (Pubitemid 36960914)
48. Verdejo-García A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neuroscience and Biobehavioral Reviews 2008; 32(4): 777-810. doi: 10.1016/j.neubiorev.2007.11.003.
49. Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Psychophysiological determinants and concomitants of deficient decision making in pathological gamblers. Drug and Alcohol Dependence 2006; 84(3): 231-239. doi: 10.1016/j.drugalcdep.2006.02.007.
50. Robbins TW. Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 2007; 362(1481): 917-932. doi: 10.1098/rstb.2007.2097.
51. Li CR, Huang C, Yan P, Bhagwagar Z, Milivojevic V, Sinha R. Neural correlates of impulse control during stop signal inhibition in cocaine-dependent men. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2008; 33(8): 1798-1806. doi:10.1038/sj.npp.1301568.
52. van Hoist RJ, van den Brink W, Veltman DJ, Goudriaan AE. Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling. Neuroscience and Biobehavioral Reviews 2010; 34(1): 87-107. doi: 10.10167j.neubiorev.2009.07.007.
53. Esposito-Smythers C, Spirito A, Rizzo C, McGeary JE, Knopik VS. (2009). Associations of the DRD2 TaqlA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents. Pharmacology, Biochemistry, and Behavior 2009; 93(3): 306-312. doi: 10.1016/j.pbb.2009.03.012.
54. Volkow ND, Wang G, Fowler JS, Thanos PPK, Logan J, Gatley SJ, et al. Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse (New York, N.Y.) 2002; 46(2): 79-82. doi: 10.1002/syn.10137.
55. Morgan D, Grant KA, Gage HD, Mach RH, Kaplan JR, Prioleau O, et al. Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nature Neuroscience 2002; 5(2): 169-174. doi: 10.1038/nn798.
56. Volkow ND, Wang G, Fowler JS, Telang F. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 2008; 363(1507): 3191-3200. doi: 10.1098/rstb.2008.0107.
57. Wang G, Volkow ND, Thanos PK, Fowler JS. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. Journal of Addictive Diseases 2004; 23(3): 39-53. (Pubitemid 39045340)
58. Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfà F. Prevalence of pathological gambling in patients with PD. Movement Disorders: Official Journal of the Movement Disorder Society 2006; 21(12): 2068-2072. doi: 10.1002/mds.21072. (Pubitemid 46140413)
59. Giladi N, Weitzman N, Schreiber S, Shabtai H, Peretz C. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with PD: the role of dopamine agonist treatment and age at motor symptoms onset. Journal of Psychopharmacology (Oxford, England) 2007; 21(5): 501-506. doi: 10.1177/0269881106073109.
60. Shaffer HJ, Hall MN, Vander Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. American Journal of Public Health 1999; 89(9): 1369-1376.
61. Koran LM, Faber RJ, Aboujaoude E, Large MD, Serpe RT. Estimated prevalence of compulsive buying behavior in the United States. The American Journal of Psychiatry 2006; 163(10): 1806-1812. doi: 10.1176/appi.ajp.163.10. 1806.
62. Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE. Pathological gambling caused by drugs used to treat Parkinson disease. Archives of Neurology 2005; 62(9): 1377-1381. doi: 10.1001/archneur.62.9.noc50009.
63. Pontone G, Williams JR, Bassett SS, Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 2006; 67(7): 1258-1261. doi: 10.1212/01.wnl.0000238401.76928.45.
64. Kish SJ, Shannak K, Homykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic PD. Pathophysiologic and clinical implications. The New England Journal of Medicine 1988; 318(14): 876-880.
65. Maruya H, Watanabe Y, Okita M, Lawlor GF, Utsumi H, Niitsuma T. Inhibitory effects of D2 agonists by striatal injection on excessive release of dopamine and hyperactivity induced by Bay K 8644 in rats. Neuroscience 2003; 118(4): 1091-1098.
66. Abler B, Hahlbrock R, Unrath A, Grön G, Kassubek J. At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists. Brain: A Journal of Neurology 2009; 132(Pt 9): 2396-2402. doi: 10.1093/brain/awp170.
67. Petry NM. Substance abuse, pathological gambling, and impulsiveness. Drug and Alcohol Dependence 2001; 63(1): 29-38.
68. Volkow ND, Fowler JS, Wang G, Swanson JM, Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Archives of Neurology 2007; 64(11): 1575-1579. doi: 10.1001/archneur.64.11.1575.